RxDoctor Payments Data

Michela Termechi

Family · Pasadena, CANPI 1437696226

Payments from drug & device makers

$6,501in general payments, 2019–2025

Across 424 payments — averaging $15.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
  • AbbVie$865
  • Forte Bio-pharma LLC$715
  • Collegium Pharmaceutical, Inc.$561
  • Boston Scientific$437
  • Medtronic$320
  • plus $3K from 28 others

What the payments were for

  • Food & beverage$6,501100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,501 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.

See all family providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
BelbucaBuprenorphine Hcl80$60,504
ZtlidoLidocaine41$27,886
Lidocaine207$20,917
MovantikNaloxegol Oxalate40$15,869
Diclofenac Sodium170$15,598
Diclofenac Potassium34$12,566
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen631$12,006
Buprenorphine34$10,348
Xtampza ErOxycodone Myristate20$9,450
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen320$9,102
OxycontinOxycodone Hcl16$7,931
Naproxen-Esomeprazole MagNaproxen/Esomeprazole Mag15$7,736
Gabapentin708$6,009
Fentanyl46$5,738
SavellaMilnacipran Hcl12$5,706

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er$561$69,954100 claims
Scilex Pharmaceuticals Inc.Ztlido$266$27,88641 claims
Redhill Biopharma Inc.Movantik$102$15,86940 claims
Hikma Pharmaceuticals USABuprenorphine, Morphine Sulfate$59$11,47993 claims
AbbVieSavella$865$5,70612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,634 family providers in California.

Other family in Pasadena

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →